Copyright Reports & Markets. All rights reserved.

Global Polysaccharide Hemostatic System (PHS) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Polysaccharide Hemostatic System (PHS) Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Automatic
    • 1.3.3 Semi-automatic
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Polysaccharide Hemostatic System (PHS) Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Polysaccharide Hemostatic System (PHS) Market Size & Forecast
    • 1.5.1 Global Polysaccharide Hemostatic System (PHS) Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Polysaccharide Hemostatic System (PHS) Sales Quantity (2020-2031)
    • 1.5.3 Global Polysaccharide Hemostatic System (PHS) Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 OLYMPUS
    • 2.1.1 OLYMPUS Details
    • 2.1.2 OLYMPUS Major Business
    • 2.1.3 OLYMPUS Polysaccharide Hemostatic System (PHS) Product and Services
    • 2.1.4 OLYMPUS Polysaccharide Hemostatic System (PHS) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 OLYMPUS Recent Developments/Updates
  • 2.2 CryoLife
    • 2.2.1 CryoLife Details
    • 2.2.2 CryoLife Major Business
    • 2.2.3 CryoLife Polysaccharide Hemostatic System (PHS) Product and Services
    • 2.2.4 CryoLife Polysaccharide Hemostatic System (PHS) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 CryoLife Recent Developments/Updates
  • 2.3 Baxter
    • 2.3.1 Baxter Details
    • 2.3.2 Baxter Major Business
    • 2.3.3 Baxter Polysaccharide Hemostatic System (PHS) Product and Services
    • 2.3.4 Baxter Polysaccharide Hemostatic System (PHS) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Baxter Recent Developments/Updates

3 Competitive Environment: Polysaccharide Hemostatic System (PHS) by Manufacturer

  • 3.1 Global Polysaccharide Hemostatic System (PHS) Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Polysaccharide Hemostatic System (PHS) Revenue by Manufacturer (2020-2025)
  • 3.3 Global Polysaccharide Hemostatic System (PHS) Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Polysaccharide Hemostatic System (PHS) by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Polysaccharide Hemostatic System (PHS) Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Polysaccharide Hemostatic System (PHS) Manufacturer Market Share in 2024
  • 3.5 Polysaccharide Hemostatic System (PHS) Market: Overall Company Footprint Analysis
    • 3.5.1 Polysaccharide Hemostatic System (PHS) Market: Region Footprint
    • 3.5.2 Polysaccharide Hemostatic System (PHS) Market: Company Product Type Footprint
    • 3.5.3 Polysaccharide Hemostatic System (PHS) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Polysaccharide Hemostatic System (PHS) Market Size by Region
    • 4.1.1 Global Polysaccharide Hemostatic System (PHS) Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Polysaccharide Hemostatic System (PHS) Consumption Value by Region (2020-2031)
    • 4.1.3 Global Polysaccharide Hemostatic System (PHS) Average Price by Region (2020-2031)
  • 4.2 North America Polysaccharide Hemostatic System (PHS) Consumption Value (2020-2031)
  • 4.3 Europe Polysaccharide Hemostatic System (PHS) Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Polysaccharide Hemostatic System (PHS) Consumption Value (2020-2031)
  • 4.5 South America Polysaccharide Hemostatic System (PHS) Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Polysaccharide Hemostatic System (PHS) Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Polysaccharide Hemostatic System (PHS) Sales Quantity by Type (2020-2031)
  • 5.2 Global Polysaccharide Hemostatic System (PHS) Consumption Value by Type (2020-2031)
  • 5.3 Global Polysaccharide Hemostatic System (PHS) Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Polysaccharide Hemostatic System (PHS) Sales Quantity by Application (2020-2031)
  • 6.2 Global Polysaccharide Hemostatic System (PHS) Consumption Value by Application (2020-2031)
  • 6.3 Global Polysaccharide Hemostatic System (PHS) Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Polysaccharide Hemostatic System (PHS) Sales Quantity by Type (2020-2031)
  • 7.2 North America Polysaccharide Hemostatic System (PHS) Sales Quantity by Application (2020-2031)
  • 7.3 North America Polysaccharide Hemostatic System (PHS) Market Size by Country
    • 7.3.1 North America Polysaccharide Hemostatic System (PHS) Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Polysaccharide Hemostatic System (PHS) Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Polysaccharide Hemostatic System (PHS) Sales Quantity by Type (2020-2031)
  • 8.2 Europe Polysaccharide Hemostatic System (PHS) Sales Quantity by Application (2020-2031)
  • 8.3 Europe Polysaccharide Hemostatic System (PHS) Market Size by Country
    • 8.3.1 Europe Polysaccharide Hemostatic System (PHS) Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Polysaccharide Hemostatic System (PHS) Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Polysaccharide Hemostatic System (PHS) Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Polysaccharide Hemostatic System (PHS) Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Polysaccharide Hemostatic System (PHS) Market Size by Region
    • 9.3.1 Asia-Pacific Polysaccharide Hemostatic System (PHS) Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Polysaccharide Hemostatic System (PHS) Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Polysaccharide Hemostatic System (PHS) Sales Quantity by Type (2020-2031)
  • 10.2 South America Polysaccharide Hemostatic System (PHS) Sales Quantity by Application (2020-2031)
  • 10.3 South America Polysaccharide Hemostatic System (PHS) Market Size by Country
    • 10.3.1 South America Polysaccharide Hemostatic System (PHS) Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Polysaccharide Hemostatic System (PHS) Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Polysaccharide Hemostatic System (PHS) Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Polysaccharide Hemostatic System (PHS) Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Polysaccharide Hemostatic System (PHS) Market Size by Country
    • 11.3.1 Middle East & Africa Polysaccharide Hemostatic System (PHS) Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Polysaccharide Hemostatic System (PHS) Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Polysaccharide Hemostatic System (PHS) Market Drivers
  • 12.2 Polysaccharide Hemostatic System (PHS) Market Restraints
  • 12.3 Polysaccharide Hemostatic System (PHS) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Polysaccharide Hemostatic System (PHS) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Polysaccharide Hemostatic System (PHS)
  • 13.3 Polysaccharide Hemostatic System (PHS) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Polysaccharide Hemostatic System (PHS) Typical Distributors
  • 14.3 Polysaccharide Hemostatic System (PHS) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Polysaccharide Hemostatic System (PHS) market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Polysaccharide Hemostatic System (PHS) is a medical device for hemostasis consisting of absorbable modified polymer (AMP) particles and a drug delivery device. It is usually used in surgery or trauma care. It uses polysaccharides (such as gelatin, alginate, etc.) as the main component, which can quickly form gels and promote blood coagulation, thereby effectively controlling bleeding.
    This report is a detailed and comprehensive analysis for global Polysaccharide Hemostatic System (PHS) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Polysaccharide Hemostatic System (PHS) market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
    Global Polysaccharide Hemostatic System (PHS) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
    Global Polysaccharide Hemostatic System (PHS) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
    Global Polysaccharide Hemostatic System (PHS) market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Polysaccharide Hemostatic System (PHS)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Polysaccharide Hemostatic System (PHS) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include OLYMPUS, CryoLife, Baxter, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Polysaccharide Hemostatic System (PHS) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Automatic
    Semi-automatic
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    OLYMPUS
    CryoLife
    Baxter
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Polysaccharide Hemostatic System (PHS) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Polysaccharide Hemostatic System (PHS), with price, sales quantity, revenue, and global market share of Polysaccharide Hemostatic System (PHS) from 2020 to 2025.
    Chapter 3, the Polysaccharide Hemostatic System (PHS) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Polysaccharide Hemostatic System (PHS) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Polysaccharide Hemostatic System (PHS) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Polysaccharide Hemostatic System (PHS).
    Chapter 14 and 15, to describe Polysaccharide Hemostatic System (PHS) sales channel, distributors, customers, research findings and conclusion.

    Buy now